MarketBeat Instant News Alerts 2 hours agoAnteris Technologies Global (AVR) to Release Quarterly Earnings on TuesdayMarketBeatAnteris Technologies Global (NASDAQ:AVR) will be releasing its Q2 2025 earnings before the market opens on Tuesday, August 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-8-12-anteris-technologies-global-corp-stock/)NASDAQ:AVRRead Anteris Technologies Global (AVR) to Release Quarterly Earnings on Tuesday2 hours agoNano-X Imaging (NNOX) to Release Quarterly Earnings on TuesdayMarketBeatNano-X Imaging (NASDAQ:NNOX) will be releasing its Q2 2025 earnings before the market opens on Tuesday, August 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-8-12-nano-x-imaging-ltd-stock/)NASDAQ:NNOXRead Nano-X Imaging (NNOX) to Release Quarterly Earnings on Tuesday2 hours agoPulse Biosciences (PLSE) to Release Earnings on TuesdayMarketBeatPulse Biosciences (NASDAQ:PLSE) will be releasing its Q2 2025 earnings after the market closes on Tuesday, August 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-8-12-pulse-biosciences-inc-stock/)NASDAQ:PLSERead Pulse Biosciences (PLSE) to Release Earnings on Tuesday2 hours agoMadrigal Pharmaceuticals (NASDAQ:MDGL) Posts Earnings Results, Beats Expectations By $1.58 EPSMarketBeatMadrigal Pharmaceuticals (NASDAQ:MDGL - Get Free Report) posted its earnings results on Tuesday. The biopharmaceutical company reported ($1.90) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.64) by $1.74. Madrigal Pharmaceuticals had a negative net margin of 123.38% and a negative return on equity of 50.54%. Madrigal Pharmaceuticals's revenue for the quarter was up 1357.5% on a year-over-year basis. During the same quarter last year, the business posted ($7.10) earnings per share. NASDAQ:MDGLRead Madrigal Pharmaceuticals (NASDAQ:MDGL) Posts Earnings Results, Beats Expectations By $1.58 EPS2 hours agoMoonLake Immunotherapeutics (NASDAQ:MLTX) Issues Earnings Results, Misses Expectations By $0.14 EPSMarketBeatMoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.87) EPS for the quarter, missing analysts' consensus estimates of ($0.73) by ($0.14). During the same period last year, the company posted ($0.39) EPS. NASDAQ:MLTXRead MoonLake Immunotherapeutics (NASDAQ:MLTX) Issues Earnings Results, Misses Expectations By $0.14 EPS2 hours agoKindlyMD (NASDAQ:NAKA) Announces Quarterly Earnings ResultsMarketBeatKindlyMD (NASDAQ:NAKA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.34) earnings per share (EPS) for the quarter. KindlyMD had a negative net margin of 177.01% and a negative return on equity of 146.26%. NASDAQ:NAKARead KindlyMD (NASDAQ:NAKA) Announces Quarterly Earnings Results Trending News1Archer Aviation (ACHR) Expected to Announce Earnings on Monday2CRISPR Therapeutics (NASDAQ:CRSP) Issues Quarterly Earnings Results, Beats Expectations By $0.18 EPS3Carol B. Tome Acquires 11,682 Shares of United Parcel Service, Inc. (NYSE:UPS) Stock4Federated Hermes Inc. Acquires 1,122,535 Shares of Virgin Galactic Holdings, Inc. (NYSE:SPCE)5Archer Aviation (NYSE:ACHR) Trading 4.1% Higher After Analyst Upgrade6AST SpaceMobile (ASTS) Projected to Post Earnings on Monday7Lloyds Banking Group (NYSE:LYG) Raised to Neutral at JPMorgan Chase & Co.8Circle Internet Group (NYSE:CRCL) Shares Down 7.1% - Time to Sell? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Alert Type Keywords 2 hours agoSantacruz Silver Mining (CVE:SCZ) Trading 20% Higher - Here's What HappenedMarketBeatCVE:SCZRead Santacruz Silver Mining (CVE:SCZ) Trading 20% Higher - Here's What Happened2 hours agoDomino's Pizza Group (LON:DOM) Stock Price Down 17.6% - Should You Sell?MarketBeatLON:DOMRead Domino's Pizza Group (LON:DOM) Stock Price Down 17.6% - Should You Sell?2 hours agoSynthomer (LON:SYNT) Stock Price Down 20.1% - Time to Sell?MarketBeatLON:SYNTRead Synthomer (LON:SYNT) Stock Price Down 20.1% - Time to Sell?2 hours agoGraphite One (CVE:GPH) Trading Down 13.1% - Here's WhyMarketBeatCVE:GPHRead Graphite One (CVE:GPH) Trading Down 13.1% - Here's Why2 hours agoSantacruz Silver Mining (CVE:SCZ) Trading Up 20% - What's Next?MarketBeatCVE:SCZRead Santacruz Silver Mining (CVE:SCZ) Trading Up 20% - What's Next?2 hours agoSantacruz Silver Mining (CVE:SCZ) Stock Price Up 20% - Here's WhyMarketBeatCVE:SCZRead Santacruz Silver Mining (CVE:SCZ) Stock Price Up 20% - Here's Why2 hours agoDomino's Pizza Group (LON:DOM) Trading Down 17.6% - Here's What HappenedMarketBeatLON:DOMRead Domino's Pizza Group (LON:DOM) Trading Down 17.6% - Here's What Happened2 hours agoSynthomer (LON:SYNT) Shares Down 20.1% - Here's What HappenedMarketBeatLON:SYNTRead Synthomer (LON:SYNT) Shares Down 20.1% - Here's What Happened2 hours agoQudian (NYSE:QD) Stock Price Down 8% - Should You Sell?MarketBeatNYSE:QDRead Qudian (NYSE:QD) Stock Price Down 8% - Should You Sell?2 hours agoTutor Perini (NYSE:TPC) Shares Down 57.8% - What's Next?MarketBeatNYSE:TPCRead Tutor Perini (NYSE:TPC) Shares Down 57.8% - What's Next?2 hours agoAdaptHealth (NASDAQ:AHCO) Trading Up 8.7% - What's Next?MarketBeatNASDAQ:AHCORead AdaptHealth (NASDAQ:AHCO) Trading Up 8.7% - What's Next?2 hours agoChart Industries (NYSE:GTLS) Sees Unusually-High Trading Volume - Here's WhyMarketBeatNYSE:GTLSRead Chart Industries (NYSE:GTLS) Sees Unusually-High Trading Volume - Here's Why2 hours agoKingdee International Software Group (OTCMKTS:KGDEY) Hits New 52-Week High - What's Next?MarketBeatOTCMKTS:KGDEYRead Kingdee International Software Group (OTCMKTS:KGDEY) Hits New 52-Week High - What's Next?2 hours agoBeOne Medicines (NASDAQ:ONC) Hits New 52-Week High - Here's WhyMarketBeatNASDAQ:ONCRead BeOne Medicines (NASDAQ:ONC) Hits New 52-Week High - Here's Why2 hours agoBeximco Pharmaceuticals (LON:BXP) Hits New 12-Month High - Time to Buy?MarketBeatLON:BXPRead Beximco Pharmaceuticals (LON:BXP) Hits New 12-Month High - Time to Buy?2 hours agoUniti Group Target of Unusually High Options Trading (NASDAQ:UNIT)MarketBeatNASDAQ:UNITRead Uniti Group Target of Unusually High Options Trading (NASDAQ:UNIT)2 hours agoRoku (NASDAQ:ROKU) Trading Up 2.6% - Time to Buy?MarketBeatNASDAQ:ROKURead Roku (NASDAQ:ROKU) Trading Up 2.6% - Time to Buy?2 hours agoAbbVie (NYSE:ABBV) Stock Price Down 1.5% - Here's What HappenedMarketBeatNYSE:ABBVRead AbbVie (NYSE:ABBV) Stock Price Down 1.5% - Here's What Happened2 hours agoApplied Materials (NASDAQ:AMAT) Stock Price Down 1.6% - Should You Sell?MarketBeatNASDAQ:AMATRead Applied Materials (NASDAQ:AMAT) Stock Price Down 1.6% - Should You Sell?2 hours agoCrowdStrike (NASDAQ:CRWD) Stock Price Up 1.1% - Here's WhyMarketBeatNASDAQ:CRWDRead CrowdStrike (NASDAQ:CRWD) Stock Price Up 1.1% - Here's Why2 hours agoWolfspeed (NYSE:WOLF) Trading Down 1.7% - Should You Sell?MarketBeatNYSE:WOLFRead Wolfspeed (NYSE:WOLF) Trading Down 1.7% - Should You Sell?2 hours agoDell Technologies (NYSE:DELL) Trading Down 2.9% - Should You Sell?MarketBeatNYSE:DELLRead Dell Technologies (NYSE:DELL) Trading Down 2.9% - Should You Sell?2 hours agoLZ Technology (NASDAQ:LZMH) Stock Price Down 29.4% - Should You Sell?MarketBeatNASDAQ:LZMHRead LZ Technology (NASDAQ:LZMH) Stock Price Down 29.4% - Should You Sell?2 hours agoLam Research (NASDAQ:LRCX) Trading Down 1.8% - What's Next?MarketBeatNASDAQ:LRCXRead Lam Research (NASDAQ:LRCX) Trading Down 1.8% - What's Next? Featured Articles and OffersThis Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army ContractMusk’s Project Colossus could mint millionairesFrom Brownstone Research(Ad)View Musk’s Project Colossus could mint millionaires5 Stocks to Buy in August With Tremendous Upside PotentialBy Thomas Hughes | July 31, 2025View 5 Stocks to Buy in August With Tremendous Upside PotentialBitcoin and Dividends: A Winning Combo in These 3 ETFsBy Nathan Reiff | August 2, 2025View Bitcoin and Dividends: A Winning Combo in These 3 ETFsGolden Cross Alert: 3 Stocks With Serious Upside PotentialBy Chris Markoch | July 31, 2025View Golden Cross Alert: 3 Stocks With Serious Upside PotentialThe Trump Dump is starting; Get out of stocks now?From Paradigm Press(Ad)View The Trump Dump is starting; Get out of stocks now?Rocket Lab Reports Next Week: Here’s What Investors Should KnowBy Ryan Hasson | August 1, 2025View Rocket Lab Reports Next Week: Here’s What Investors Should Know2 Cybersecurity Giants Nearing Big Potential BreakoutsBy Ryan Hasson | July 31, 2025View 2 Cybersecurity Giants Nearing Big Potential Breakouts Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
